AIDX compared with SPAI: revenue, margins and what each company keeps, and the suppliers and customers both name

AIDX20/20 Biolabs, Inc.

Mkt capRevenueRevenue

SPAISafe Pro Group Inc.

Mkt capRevenueRevenue

Compare

AIDX20/20 Biolabs, Inc.

SPAISafe Pro Group Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

AIDX1 of 4 reports

Reportimpliedrealized× implied

Q2 FY26—▼−6.21%—

SPAI2 of 4 reports

1 of 1at or beyond implied

Reportimpliedrealized× implied

Oct 7 '26—▲+14.88%—

Q2 FY26±16.1%▲+37.72%×2.34

= impliedAIDX realized, solidSPAI realized, hatchedOne scale, both sides: full bar = 38%× = |realized| ÷ impliedSource: market data

AIDX20/20 Biolabs, Inc.

0.19▼−19.18%

Mkt cap$2.0MRevenue$730,571Q2 FY26Revenue—

SPAISafe Pro Group Inc.

2.88▲+4.35%

Regular sessionNov 6 '26

Mkt cap$56.6MRevenue$1MQ2 FY26Revenue$606,681FY25

Compare

Regular sessionNov 6 '26

AIDX20/20 Biolabs, Inc.

SPAISafe Pro Group Inc.

0.19▼−19.18%

Price

2.88▲+4.35%

$2.0M

Mkt cap

$56.6M

Q2 FY26$730,571

Revenue

$1MQ2 FY26

—

Revenue

$606,681FY25

AIDX0.19▼−19.18%vsSPAI2.88▲+4.35%Regular sessionNov 6 '26